Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348)

HKG:2348 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 21, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,999	1,832	1,575	1,993	2,502	2,107
Market Cap Growth	16.32%	16.32%	-20.98%	-20.34%	18.77%	-5.13%
Enterprise Value	328	221	503	1,004	1,638	1,060
Last Close Price	1.33	1.14	0.92	1.08	1.26	0.99
PE Ratio	3.33	3.05	4.39	4.93	5.69	6.62
Forward PE	-	7.84	7.84	7.84	7.84	7.84
PS Ratio	1.77	1.62	1.24	1.38	1.75	1.73
PB Ratio	0.56	0.52	0.50	0.67	0.85	0.81
P/TBV Ratio	0.64	0.59	0.58	0.77	1.00	0.94
P/FCF Ratio	19.95	18.29	10.30	7.67	25.46	10.83
P/OCF Ratio	8.53	7.82	4.22	4.06	5.19	5.86
EV/Sales Ratio	0.29	0.20	0.40	0.70	1.15	0.87
EV/EBITDA Ratio	1.02	0.69	1.29	1.85	3.08	2.39
EV/EBIT Ratio	1.55	1.03	1.65	2.12	3.51	2.79
EV/FCF Ratio	3.27	2.21	3.29	3.87	16.67	5.45
Debt / Equity Ratio	0.01	0.01	0.04	0.00	0.01	0.00
Debt / EBITDA Ratio	0.11	0.11	0.34	0.02	0.05	0.01
Debt / FCF Ratio	0.37	0.37	0.87	0.04	0.29	0.02
Asset Turnover	0.28	0.28	0.32	0.36	0.37	0.36
Inventory Turnover	2.03	2.03	2.31	2.30	2.18	2.24
Quick Ratio	3.38	3.38	2.24	1.59	1.72	2.69
Current Ratio	3.97	3.97	2.57	1.87	2.17	3.23
Return on Equity (ROE)	18.20%	18.20%	11.71%	14.10%	15.46%	12.58%
Return on Assets (ROA)	3.31%	3.31%	4.73%	7.47%	7.62%	7.04%
Return on Capital (ROIC)	3.98%	3.98%	6.12%	10.31%	10.33%	9.04%
Return on Capital Employed (ROCE)	5.80%	5.80%	9.30%	15.30%	14.40%	13.20%
Earnings Yield	30.07%	32.81%	22.80%	20.31%	17.57%	15.11%
FCF Yield	5.01%	5.47%	9.71%	13.04%	3.93%	9.23%
Dividend Yield	4.60%	5.53%	8.74%	8.15%	6.33%	6.55%
Payout Ratio	19.68%	19.68%	35.91%	27.80%	40.18%	30.44%
Buyback Yield / Dilution	-0.22%	-0.22%	-0.02%	0.37%	2.44%	1.89%
Total Shareholder Return	4.38%	5.31%	8.72%	8.52%	8.77%	8.44%

Updated Sep 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.